ScinoPharm Taiwan Ltd
TWSE:1789
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
TW |
|
Perpetua Resources Corp
TSX:PPTA
|
CA |
|
Sparebank 1 Sor-Norge ASA
F:B4M1
|
NO |
|
B
|
Baker Hughes Co
F:68V
|
US |
|
Leon's Furniture Ltd
TSX:LNF
|
CA |
|
S
|
SugenTech Inc
KOSDAQ:253840
|
KR |
|
Santacruz Silver Mining Ltd
F:1SZ0
|
CA |
|
Z
|
Zoetis Inc
SWB:ZOE
|
US |
|
J
|
Jiangnan Mould & Plastic Technology Co Ltd
SZSE:000700
|
CN |
|
PTC India Financial Services Ltd
NSE:PFS
|
IN |
|
P
|
Premier Marketing PCL
SET:PM
|
TH |
|
F
|
Fastenal Co
XHAM:FAS
|
US |
|
Superior Group of Companies Inc
NASDAQ:SGC
|
US |
|
Waraba Gold Ltd
F:ZE00
|
CA |
|
P
|
Pakistan International Bulk Terminal Ltd
KAR:PIBTL
|
PK |
|
Pan Global Resources Inc
XTSX:PGZ
|
CA |
|
C
|
Chanson International Holding
NASDAQ:CHSN
|
CN |
Bankruptcy Probability
ScinoPharm Taiwan Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
ScinoPharm Taiwan Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TW |
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
15.4B TWD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
644.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
382.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
363.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
245B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
198.9B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
264.4B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
173.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
128.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
ScinoPharm Taiwan Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, ScinoPharm Taiwan Ltd has total debt of 849.6m TWD. This includes both short-term (185.2m TWD) and long-term (664.4m TWD) debt.
You can find a full breakdown on its Balance Sheet.